<!--#set var="title" value="Genbank References: capsid (p24)" --> <!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

Genbank References: capsid (p24)

AuthorsTitleCitationE-value# in
Gb		#PtsARTSourceCloningStudyType
Persaud (2016) Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy AIDS Res. Hum. Retroviruses 23 (3), 381-390 (2007) 8.95e-169 94 12 ART Plasma; PBMC SGS Reservoir

Download sequences

AccessionIsolateNameCountryColl DateCloneMolTypeSourceNoteFirstAALastAAMutList
EF457099105_m29_c5M3_2USA: Maryland, Balti5M3_2genomic RNAresting CD4 lymphocytes; time point 29months of HAART12316L,15L,41T,91V,154K,194S
EF457100105_m32_c5M5_2USA: Maryland, Balti5M5_2genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,15L,41T,88V,91V,154K,194S
EF457101105_m32_c5M5_3USA: Maryland, Balti5M5_3genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,15L,41T,91V,154K,194S
EF457110106_m56_c5M3_1_1USA: Maryland, Balti5M3_1_1genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457111106_m56_c5M3_1_2USA: Maryland, Balti5M3_1_2genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457112106_m56_c5M3_1_3USA: Maryland, Balti5M3_1_3genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457113106_m56_c5M3_2_1USA: Maryland, Balti5M3_2_1genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457114106_m56_c5M3_2_2USA: Maryland, Balti5M3_2_2genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457115106_m56_c5M5_1_1USA: Maryland, Balti5M5_1_1genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457116106_m56_c5M5_1_2USA: Maryland, Balti5M5_1_2genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457117106_m56_c5M5_2_2USA: Maryland, Balti5M5_2_2genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457118106_m56_c5M5_2_3USA: Maryland, Balti5M5_2_3genomic RNAresting CD4 lymphocytes; time point 56months of HAART12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,184*,216P,225S
EF457102106_p_1_2USA: Maryland, Baltip_1_2genomic RNAplasma; pre-treatment time point12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457103106_p_1_3USA: Maryland, Baltip_1_3genomic RNAplasma; pre-treatment time point12316L,27I,30R,36I,79D,83L,96L,116A,120H,128G,148S,154K,180D,216S,225S
EF457104106_p_1_4USA: Maryland, Baltip_1_4genomic RNAplasma; pre-treatment time point12316L,27I,30R,36I,79D,83L,91T,96L,116A,120H,128D,140R,148S,154K,180D,216S,225S
EF457105106_p_2_1USA: Maryland, Baltip_2_1genomic RNAplasma; pre-treatment time point12316L,8W,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457106106_p_2_2USA: Maryland, Baltip_2_2genomic RNAplasma; pre-treatment time point12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457107106_p_2_3USA: Maryland, Baltip_2_3genomic RNAplasma; pre-treatment time point12316L,27I,30R,36I,45G,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457108106_p_2_4USA: Maryland, Baltip_2_4genomic RNAplasma; pre-treatment time point12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,216S,225S
EF457109106_p_2_5USA: Maryland, Baltip_2_5genomic RNAplasma; pre-treatment time point12316L,27I,30R,36I,79D,83L,96L,116A,120H,128D,148S,154K,180D,195D,216S,225S
EF457126107_m11_c5M2_2USA: Maryland, Balti5M2_2genomic RNAresting CD4 lymphocytes; time point 11months of HAART12314R,6L,41A,83L,86T,91V,116D,132K,136M,154K,180D
EF457127107_m11_c5M3_BUSA: Maryland, Balti5M3_Bgenomic RNAresting CD4 lymphocytes; time point 11months of HAART12314R,6L,41A,83L,86T,91V,116D,119A,132K,136M,149N,154K,180D
EF457121107_m5_c1A1_1USA: Maryland, Balti1A1_1genomic RNAresting CD4 lymphocytes; time point 5months of HAART12314R,6L,14T,41A,83L,86T,91V,116D,132K,136K,145C,154K,180D
EF457122107_m5_c1A1_2USA: Maryland, Balti1A1_2genomic RNAresting CD4 lymphocytes; time point 5months of HAART12314R,6L,41A,50R,83L,86T,91V,116D,132K,136M,154K,180D
EF457123107_m5_c1A1_3USA: Maryland, Balti1A1_3genomic RNAresting CD4 lymphocytes; time point 5months of HAART12314R,6L,41A,83L,86T,91V,116D,132K,136M,154K,180D
EF457124107_m5_c1A2_1USA: Maryland, Balti1A2_1genomic RNAresting CD4 lymphocytes; time point 5months of HAART12314R,6L,41A,83L,86T,91V,116D,132K,136M,154K,180D
EF457125107_m5_c1A2_3USA: Maryland, Balti1A2_3genomic RNAresting CD4 lymphocytes; time point 5months of HAART12314R,6L,41A,83L,86T,91V,116D,132K,136M,154K,180D
EF457119107_p_1_5USA: Maryland, Baltip_1_5genomic RNAplasma; pre-treatment time point12314R,6L,41A,83L,86T,91V,116D,132K,136M,154K,180D
EF457120107_p_2_1USA: Maryland, Baltip_2_1genomic RNAplasma; pre-treatment time point12314R,6L,41A,83L,86T,91V,116D,123L,132K,136M,154K,180D
EF457133108_m24_c1B_1_2_USA: Maryland, Balti1B_1_2_genomic RNAresting CD4 lymphocytes; time point 24months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,129L,148V,154K,180D,203R,225S
EF457134108_m24_c1B_1_3_USA: Maryland, Balti1B_1_3_genomic RNAresting CD4 lymphocytes; time point 24months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457135108_m24_c1B_1_4_USA: Maryland, Balti1B_1_4_genomic RNAresting CD4 lymphocytes; time point 24months of HAART12316L,14P,16T,26A,33G,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457136108_m24_c1B_1_5_USA: Maryland, Balti1B_1_5_genomic RNAresting CD4 lymphocytes; time point 24months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457137108_m30_c5M6_1_1USA: Maryland, Balti5M6_1_1genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457138108_m30_c5M6_1_2USA: Maryland, Balti5M6_1_2genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457139108_m30_c5M6_1_3USA: Maryland, Balti5M6_1_3genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457140108_m30_c5M6_1_4USA: Maryland, Balti5M6_1_4genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457141108_m30_c5M6_1_5USA: Maryland, Balti5M6_1_5genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457142108_m30_c5M6_2_1USA: Maryland, Balti5M6_2_1genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457143108_m30_c5M6_2_2USA: Maryland, Balti5M6_2_2genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457144108_m30_c5M6_2_3USA: Maryland, Balti5M6_2_3genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457145108_m30_c5M6_2_4USA: Maryland, Balti5M6_2_4genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457146108_m30_c5M6_3_1USA: Maryland, Balti5M6_3_1genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457147108_m30_c5M6_3_2USA: Maryland, Balti5M6_3_2genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,93S,110S,120S,148V,154K,180D,203R,225S
EF457148108_m30_c5M6_3_3USA: Maryland, Balti5M6_3_3genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457149108_m30_c5M8_1_1USA: Maryland, Balti5M8_1_1genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457150108_m30_c5M8_1_2USA: Maryland, Balti5M8_1_2genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457151108_m30_c5M8_1_3USA: Maryland, Balti5M8_1_3genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,47V,59I,83L,87Q,110S,120S,148V,154K,155R,180D,185V,203R,225S
EF457152108_m30_c5M8_1_4USA: Maryland, Balti5M8_1_4genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457153108_m30_c5M8_1_5USA: Maryland, Balti5M8_1_5genomic RNAresting CD4 lymphocytes; time point 30months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457154108_m32_c1A_1USA: Maryland, Balti1A_1genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457155108_m32_c1A_2USA: Maryland, Balti1A_2genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,104M,110S,120S,148V,154K,180D,203R,225S
EF457156108_m32_c1A_4USA: Maryland, Balti1A_4genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457157108_m32_c1A_5USA: Maryland, Balti1A_5genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,104M,110S,120S,148V,154K,180D,203R,225S
EF457158108_m32_c5M3_1_1USA: Maryland, Balti5M3_1_1genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457159108_m32_c5M3_1_3USA: Maryland, Balti5M3_1_3genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457160108_m32_c5M3_1_4USA: Maryland, Balti5M3_1_4genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457161108_m32_c5M3_1_5USA: Maryland, Balti5M3_1_5genomic RNAresting CD4 lymphocytes; time point 32months of HAART12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,185V,203R,225S
EF457128108_p_1USA: Maryland, Baltip_1genomic RNAplasma; pre-treatment time point12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457129108_p_2USA: Maryland, Baltip_2genomic RNAplasma; pre-treatment time point12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457130108_p_3USA: Maryland, Baltip_3genomic RNAplasma; pre-treatment time point12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,218R,225S
EF457131108_p_4USA: Maryland, Baltip_4genomic RNAplasma; pre-treatment time point12316L,14P,16T,26A,41T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF457132108_p_5USA: Maryland, Baltip_5genomic RNAplasma; pre-treatment time point12316L,14P,16T,26A,41T,55T,59I,83L,87Q,110S,120S,148V,154K,180D,203R,225S
EF45719011_m0_c1USA: Maryland, Balti1genomic RNAresting CD4 lymphocytes; time point 0months of HAART12316L,27I,148V,180D,208Q
EF45719111_m0_c2USA: Maryland, Balti2genomic RNAresting CD4 lymphocytes; time point 0months of HAART12316L,27I,148V,180D,208Q
EF45719211_m0_c3USA: Maryland, Balti3genomic RNAresting CD4 lymphocytes; time point 0months of HAART12316L,27I,148V,180D,208Q,217T
EF45718711_m33_c1USA: Maryland, Balti1genomic RNAresting CD4 lymphocytes; time point 33months of HAART12316L,27I,148V,180D
EF45718811_m33_c2USA: Maryland, Balti2genomic RNAresting CD4 lymphocytes; time point 33months of HAART12316L,27I,102G,148V,180D,194T
EF45718911_m33_c3USA: Maryland, Balti3genomic RNAresting CD4 lymphocytes; time point 33months of HAART12316L,27I,148V,180D
EF457167111_m16_c5M6_1_1USA: Maryland, Balti5M6_1_1genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457168111_m16_c5M6_1_2USA: Maryland, Balti5M6_1_2genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,40I,83L,87Q,91V,116A,148V,154K
EF457169111_m16_c5M6_1_3USA: Maryland, Balti5M6_1_3genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K,219R
EF457170111_m16_c5M6_2_1USA: Maryland, Balti5M6_2_1genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457171111_m16_c5M6_2_2USA: Maryland, Balti5M6_2_2genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457172111_m16_c5M6_2_3USA: Maryland, Balti5M6_2_3genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,94S,116A,148V,154K
EF457173111_m16_c5M7_1_1USA: Maryland, Balti5M7_1_1genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457174111_m16_c5M7_1_2USA: Maryland, Balti5M7_1_2genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,36A,83L,87Q,91V,116A,148V,154K
EF457175111_m16_c5M7_1_3USA: Maryland, Balti5M7_1_3genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457176111_m16_c5M7_2_1USA: Maryland, Balti5M7_2_1genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457177111_m16_c5M7_2_2USA: Maryland, Balti5M7_2_2genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457178111_m16_c5M7_2_3USA: Maryland, Balti5M7_2_3genomic RNAresting CD4 lymphocytes; time point 16months of HAART12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457162111_p_1USA: Maryland, Baltip_1genomic RNAplasma; pre-treatment time point12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457163111_p_2USA: Maryland, Baltip_2genomic RNAplasma; pre-treatment time point12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457164111_p_3USA: Maryland, Baltip_3genomic RNAplasma; pre-treatment time point12316L,15L,27I,38L,41P,83L,87Q,91V,116A,148V,154K,168S
EF457165111_p_4USA: Maryland, Baltip_4genomic RNAplasma; pre-treatment time point12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF457166111_p_5USA: Maryland, Baltip_5genomic RNAplasma; pre-treatment time point12316L,15L,27I,83L,87Q,91V,116A,148V,154K
EF4571798_m22_c2USA: Maryland, Balti2genomic RNAresting CD4 lymphocytes; time point 22months of HAART12316L,83L,91T,120S,154K,171V,180D
EF4571808_m22_c3USA: Maryland, Balti3genomic RNAresting CD4 lymphocytes; time point 22months of HAART12316L,83L,91T,120S,154K,171V,180D
EF4571818_m38_c1USA: Maryland, Balti1genomic RNAresting CD4 lymphocytes; time point 38months of HAART12312L,6L,83L,113G,120S,171V,180D
EF4571828_m38_c2USA: Maryland, Balti2genomic RNAresting CD4 lymphocytes; time point 38months of HAART12316L,83L,120S,171V,180D
EF4571838_m38_c3USA: Maryland, Balti3genomic RNAresting CD4 lymphocytes; time point 38months of HAART12316L,83L,120S,171V,180D
EF4571848_m58_c1USA: Maryland, Balti1genomic RNAresting CD4 lymphocytes; time point 58months of HAART12316L,83L,91A,120S,154K,171V,180D
EF4571858_m58_c2USA: Maryland, Balti2genomic RNAresting CD4 lymphocytes; time point 58months of HAART12316L,83L,91A,101E,120S,154K,171V,180D
EF4571868_m58_c3USA: Maryland, Balti3genomic RNAresting CD4 lymphocytes; time point 58months of HAART12316L,22V,60R,83L,91A,120S,154K,170R,171V,180D,210A

Database

Resources

Team